Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Isomorphic Labs, a drug discovery company spun out of Google DeepMind, is about to make a historic breakthrough in medicine. The company is gearing up to begin human clinical trials for drugs designed ...

Fergus had been working at Google DeepMind as a research director for roughly five years, per his LinkedIn. Prior to Google, he worked as a researcher scientist at Meta. Meta’s FAIR, which has ...

A general view of the Google DeepMind offices after the announcement that Founder and CEO Demis Hassabis and senior research scientist, John M. Jumper, received the 2024 Nobel Prize for Chemistry ...

Google wants to dominate AI-powered online searches in all their forms, says DeepMind CEO Demis Hassabis, DeepMind CEO, offered interesting insights into the company’s path in the industry.

Google's DeepMind research division claims its newest AI agent marks a significant step toward using the technology to tackle big problems in math and science. The system, known as AlphaEvolve, is ...